Clinical Trial Update: Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

View source ↗

Summary

This completed local non-interventional study sponsored by Bayer evaluated how anticoagulation therapy is prescribed for secondary stroke prevention in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Embolism
• Stroke

Drugs mentioned

• Anticoagulation therapy (various)

Snippet

Sponsor: Bayer | Conditions: Stroke, Embolism | Status: COMPLETED